Publications 2023

Aranda-Guillén M, Røyrvik EC, Fletcher-Sandersjöö S, Artaza H, Botusan IR, Grytaas MA, Hallgren Å, Breivik L, Pettersson M, Jørgensen AP, Lindstrand A, Vogt E, Norwegian Addison Registry Study Group, The Swedish Addison Registry Study Group, Husebye ES, Kämpe O, Wolff ASB, Bensing S, Johansson S, Eriksson D (2023)
A polygenic risk score to help discriminate primary adrenal insufficiency of different etiologies
J Intern Med, 294 (1), 96-109
DOI 10.1111/joim.13649, PubMed 37151110

Kolnes AJ, Øystese KAB, Sjöstedt E, Olarescu NC, Heck A, Pahnke J, Dahlberg D, Berg-Johnsen J, Ringstad G, Casar-Borota O, Bollerslev J, Jørgensen AP (2023)
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours
Pituitary, 26 (2), 227-236
DOI 10.1007/s11102-023-01310-x, PubMed 36952069

Sævik ÅB, Ueland G, Åkerman AK, Methlie P, Quinkler M, Jørgensen AP, Höybye C, Debowska AWJ, Nedrebø BG, Dahle AL, Carlsen S, Tomkowicz A, Sollid ST, Nermoen I, Grønning K, Dahlqvist P, Grimnes G, Skov J, Finnes T, Valland SF, Wahlberg J, Holte SE, Kämpe O, Bensing S, Husebye ES et al. (2023)
Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison's disease - a cross-sectional study
Eur J Endocrinol, 189 (4), 438-447
DOI 10.1093/ejendo/lvad136, PubMed 37807083

Wolff ASB, Hansen L, Grytaas MA, Oftedal BE, Breivik L, Zhou F, Hufthammer KO, Sjøgren T, Olofsson JS, Trieu MC, Meager A, Jørgensen AP, Lima K, Greve-Isdahl Mohn K, Langeland N, Cox RJ, Husebye ES (2023)
Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies
iScience, 26 (7), 107084
DOI 10.1016/j.isci.2023.107084, PubMed 37346050

Åkerman AK, Sævik ÅB, Thorsby PM, Methlie P, Quinkler M, Jørgensen AP, Höybye C, Debowska AJ, Nedrebø BG, Dahle AL, Carlsen S, Tomkowicz A, Sollid ST, Nermoen I, Grønning K, Dahlqvist P, Grimnes G, Skov J, Finnes T, Wahlberg J, Holte SE, Simunkova K, Kämpe O, Husebye ES, Øksnes M et al. (2023)
Plasma-Metanephrines in Patients with Autoimmune Addison's Disease with and without Residual Adrenocortical Function
J Clin Med, 12 (10)
DOI 10.3390/jcm12103602, PubMed 37240708

Publications 2022

Meling Stokland AE, Ueland G, Lima K, Grønning K, Finnes TE, Svendsen M, Ewa Tomkowicz A, Emblem Holte S, Therese Sollid S, Debowska A, Singsås H, Landsverk Rensvik M, Lejon H, Sørmo DE, Svare A, Blika S, Milova P, Korsgaard E, Husby Ø, Breivik L, Jørgensen AP, Sverre Husebye E (2022)
Autoimmune Thyroid Disorders in Autoimmune Addison Disease
J Clin Endocrinol Metab, 107 (6), e2331-e2338
DOI 10.1210/clinem/dgac089, PubMed 35226748

Publications 2021

Eriksson D, Røyrvik EC, Aranda-Guillén M, Berger AH, Landegren N, Artaza H, Hallgren Å, Grytaas MA, Ström S, Bratland E, Botusan IR, Oftedal BE, Breivik L, Vaudel M, Helgeland Ø, Falorni A, Jørgensen AP, Hulting AL, Svartberg J, Ekwall O, Fougner KJ, Wahlberg J, Nedrebø BG, Dahlqvist P, Norwegian Addison Registry Study Group et al. (2021)
GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility
Nat Commun, 12 (1), 959
DOI 10.1038/s41467-021-21015-8, PubMed 33574239

Jørgensen AP (2021)
Endocrine Workup for Primary Aldosteronism Should Include Adrenal Venous Sampling in Young Patients
J Clin Endocrinol Metab, 106 (7), e2828-e2829
DOI 10.1210/clinem/dgab142, PubMed 33687060

Shukur HH, Hussain-Alkhateeb L, Farholt S, Nørregaard O, Jørgensen AP, Hoybye C (2021)
Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome
J Clin Endocrinol Metab, 106 (9), e3634-e3643
DOI 10.1210/clinem/dgab300, PubMed 33950234

Publications 2020

Eika F, Wathne OA, Jorgensen AP (2020)
Glucocorticoids with bitter taste
Tidsskr. Nor. Laegeforen., 140 (3), 277

Eika F, Wathne OA, Jørgensen AP (2020)
[Glucocorticoids with a side effect]
Tidsskr Nor Laegeforen, 140 (3)
DOI 10.4045/tidsskr.19.0495, PubMed 32105044

Grytaas MA, Breivik L, Jorgensen AP, Finnes TE, Skavlan LAD, Wiik R, Johansen KI, Husebye ES (2020)
Medical coding for discomfort
Tidsskr. Nor. Laegeforen., 140 (14), 1426-1427

Grytaas MA, Breivik L, Jørgensen AP, Finnes TE, Skavlan LAD, Wiik R, Johansen KI, Husebye ES (2020)
[The trouble with medical coding]
Tidsskr Nor Laegeforen, 140 (14)
DOI 10.4045/tidsskr.20.0541, PubMed 33070589

Kolnes AJ, Øystese KA, Dahlberg D, Berg-Johnsen J, Niehusmann P, Pahnke J, Bollerslev J, Jørgensen AP (2020)
Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma
Acta Neurochir (Wien), 162 (4), 845-852
DOI 10.1007/s00701-019-04068-z, PubMed 31907611

Kolnes AJ, Øystese KAB, Olarescu NC, Ringstad G, Berg-Johnsen J, Casar-Borota O, Bollerslev J, Jørgensen AP (2020)
FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors
J Clin Endocrinol Metab, 105 (8), 2587-94
DOI 10.1210/clinem/dgaa281, PubMed 32421791

Sjöstedt E, Kolnes AJ, Olarescu NC, Mitsios N, Hikmet F, Sivertsson Å, Lindskog C, Øystese KAB, Jørgensen AP, Bollerslev J, Casar-Borota O (2020)
TGFBR3L-An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue
Cancers (Basel), 13 (1)
DOI 10.3390/cancers13010114, PubMed 33396509

Sævik ÅB, Åkerman AK, Methlie P, Quinkler M, Jørgensen AP, Höybye C, Debowska AJ, Nedrebø BG, Dahle AL, Carlsen S, Tomkowicz A, Sollid ST, Nermoen I, Grønning K, Dahlqvist P, Grimnes G, Skov J, Finnes T, Valland SF, Wahlberg J, Holte SE, Simunkova K, Kämpe O, Husebye ES, Bensing S et al. (2020)
Residual Corticosteroid Production in Autoimmune Addison Disease
J Clin Endocrinol Metab, 105 (7), 2430-41
DOI 10.1210/clinem/dgaa256, PubMed 32392298

Publications 2017

Jorgensen AP (2017)
ENDOCRINOLOGY
Tidsskr. Nor. Laegeforen., 137 (23-24), 1955

Jørgensen AP (2017)
[Not Available]
Tidsskr Nor Laegeforen, 137 (23-24)
DOI 10.4045/tidsskr.17.0848, PubMed 29231650

Tazmini K, Meling TR, Skattør TH, Jørstad ØK, Jørgensen AP (2017)
A woman in her 50s with chronic fatigue syndrome, sepsis and hyponatraemia
Tidsskr Nor Laegeforen, 137 (5), 372-377
DOI 10.4045/tidsskr.16.0896, PubMed 28272569

Publications 2016

Bruserud Ø, Oftedal BE, Landegren N, Erichsen MM, Bratland E, Lima K, Jørgensen AP, Myhre AG, Svartberg J, Fougner KJ, Bakke Å, Nedrebø BG, Mella B, Breivik L, Viken MK, Knappskog PM, Marthinussen MC, Løvås K, Kämpe O, Wolff AB, Husebye ES (2016)
A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1
J Clin Endocrinol Metab, 101 (8), 2975-83
DOI 10.1210/jc.2016-1821, PubMed 27253668

Jørgensen AP (2016)
[Can Health-Norway be united into one kingdom?]
Tidsskr Nor Laegeforen, 136 (17), 1432
DOI 10.4045/tidsskr.16.0618, PubMed 27686201

Publications 2014

Olarescu NC, Jørgensen AP, Godang K, Jurik AG, Frøslie KF, Bollerslev J (2014)
Dual-energy X-ray absorptiometry is a valid method to estimate visceral adipose tissue in adult patients with Prader-Willi syndrome during treatment with growth hormone
J Clin Endocrinol Metab, 99 (9), E1727-31
DOI 10.1210/jc.2014-2059, PubMed 24955611

Ueland T, Olarescu NC, Jørgensen AP, Otterdal K, Aukrust P, Godang K, Lekva T, Bollerslev J (2014)
Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment
J Clin Endocrinol Metab, 100 (2), 736-43
DOI 10.1210/jc.2014-2912, PubMed 25459913

Publications 2013

Jørgensen AP (2013)
[Think holistically, think cooperation]
Tidsskr Nor Laegeforen, 133 (21), 2275
DOI 10.4045/tidsskr.13.1075, PubMed 24226337

Jørgensen AP, Ueland T, Sode-Carlsen R, Schreiner T, Rabben KF, Farholt S, Høybye C, Christiansen JS, Bollerslev J (2013)
Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study
Growth Horm IGF Res, 24 (1), 16-21
DOI 10.1016/j.ghir.2013.11.002, PubMed 24360789

Publications 2012

Husebye ES, Erichsen MM, Myhre AG, Bratke H, Jørgensen AP, Dahlqvist P, Løvås K (2012)
[New steroid card for adrenal insufficiency]
Tidsskr Nor Laegeforen, 132 (18), 2043-4
DOI 10.4045/tidsskr.12.0946, PubMed 23038193

Jørgensen AP, Bollerslev J (2012)
Bone: Growth hormone replacement--implications for bone health
Nat Rev Endocrinol, 8 (6), 325-6
DOI 10.1038/nrendo.2012.50, PubMed 22473331

Publications 2011

Jørgensen AP (2011)
[The simplest can be the best]
Tidsskr Nor Laegeforen, 131 (20), 2012
DOI 10.4045/tidsskr.11.1081, PubMed 22016129

Ueland T, Jørgensen AP, Godang K, Fougner KJ, Aukrust P, Burman P, Bollerslev J (2011)
Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency
Clin Endocrinol (Oxf), 74 (1), 60-6
DOI 10.1111/j.1365-2265.2010.03884.x, PubMed 21039720

Ueland T, Lekva T, Otterdal K, Dahl TB, Olarescu NC, Jørgensen AP, Fougner KJ, Brixen K, Aukrust P, Bollerslev J (2011)
Increased serum and bone matrix levels of transforming growth factor {beta}1 in patients with GH deficiency in response to GH treatment
Eur J Endocrinol, 165 (3), 393-400
DOI 10.1530/EJE-11-0442, PubMed 21653735

Publications 2009

Johansen OE, Birkeland KI, Jørgensen AP, Orvik E, Sørgård B, Torjussen BR, Ueland T, Aukrust P, Gullestad L (2009)
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
J Diabetes, 1 (3), 182-7
DOI 10.1111/j.1753-0407.2009.00031.x, PubMed 20923537

Johansen OE, Vanberg PJ, Kilhovd BK, Jørgensen AP (2009)
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia
Vasc Health Risk Manag, 5 (1), 121-8
PubMed 19436668

Publications 2006

Bollerslev J, Ueland T, Jørgensen AP, Fougner KJ, Wergeland R, Schreiner T, Burman P (2006)
Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency
Eur J Endocrinol, 154 (4), 537-43
DOI 10.1530/eje.1.02125, PubMed 16556716

Johansen OE, Jørgensen AP (2006)
[Glitazone treatment of type 2 diabetes mellitus]
Tidsskr Nor Laegeforen, 126 (15), 1928-30
PubMed 16915317

Publications 2005

Bollerslev J, Hallén J, Fougner KJ, Jørgensen AP, Kristo C, Fagertun H, Gudmundsen O, Burman P, Schreiner T (2005)
Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
Eur J Endocrinol, 153 (3), 379-87
DOI 10.1530/eje.1.01971, PubMed 16131600